Table 1.

List and principal characteristics of small molecules that act as Glut1 inhibitors.

Name	Structure	MW	IC50 (µ)	Characteristics	Human Cell Target (ref)
STF-31		423.53	1	Low solubility	Renal cancer RCC4 [38] CD4+ T cells [39] Beta cells [40]
WZB-117		368.31	0.5	High solubility	Multiple cancer cell lines [42] Autoreactive CD8+ T cells [25]
BAY 876		496.42	0.002	Highly selective Orally bioavailable	Colon cancer DLD1 [44]